Medications for Hypoestrogenism

3 results
Noven Therapeutics, LLC
Usage: CombiPatch is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause in women with a uterus, as well as for hypoestrogenism resulting from hypogonadism, castration, or primary ovarian failure.
Allergan, Inc.
Usage: ESTRACE (estradiol tablets USP) is indicated for treating moderate to severe menopausal symptoms (vasomotor and vulvar/vaginal atrophy), hypoestrogenism from various causes, palliative care for metastatic breast cancer and advanced prostate cancer, and prevention of postmenopausal osteoporosis in women at significant risk.
Teva Pharmaceuticals USA, Inc.
Usage: Estradiol tablets are indicated for treating moderate to severe menopause symptoms, vulvar and vaginal atrophy, hypoestrogenism, and for palliation in breast cancer and prostate cancer. They may also be used for preventing osteoporosis in postmenopausal women at significant risk when non-estrogen options are unsuitable.